Cargando…

In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens

BACKGROUND: Systemic Escherichia coli infections cause early mortality of commercial broiler chickens. Although enrofloxacin has long been used in poultry, the in vivo pharmacokinetic/pharmacodynamic (PK/PD) relationship of enrofloxacin against E. coli is unclear. The present study aimed to establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Xia, Jiang, Lijie, Lan, Weixuan, Jiang, Yongjia, Wang, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267815/ https://www.ncbi.nlm.nih.gov/pubmed/30497453 http://dx.doi.org/10.1186/s12917-018-1698-3

Ejemplares similares

Pharmacokinetic–Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers
por: Sang, KaNa, et al.
Publicado: (2016)

Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli
por: Wang, Jianyi, et al.
Publicado: (2016)

Pharmacokinetic and pharmacodynamic integration of enrofloxacin against Salmonella Enteritidis after administering to broiler chicken by per-oral and intravenous routes
por: Kang, JeongWoo, et al.
Publicado: (2019)

Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling
por: Liu, Xuesong, et al.
Publicado: (2021)

Pharmacokinetics, Pharmacodynamic Efficacy Prediction Indexes and Monte Carlo Simulations of Enrofloxacin Hydrochloride Against Bacterial Strains That Induce Common Clinical Diseases in Broiler Chickens
por: Bonassa, Karina P. D., et al.
Publicado: (2021)

Comparative Studies of Antimicrobial Resistance in Escherichia coli, Salmonella, and Campylobacter Isolates from Broiler Chickens with and without Use of Enrofloxacin
por: Shang, Ke, et al.
Publicado: (2023)

In vivo Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against Pasteurella multocida in Ducks
por: Xiao, Xia, et al.
Publicado: (2021)

Pharmacokinetic‐pharmacodynamic integration of enrofloxacin and its metabolite ciprofloxacin in buffalo calves
por: Daundkar, Prashant S., et al.
Publicado: (2015)

Enrofloxacin Dose Optimization for the Treatment of Colibacillosis in Broiler Chickens Using a Drinking Behaviour Pharmacokinetic Model
por: Temmerman, Robin, et al.
Publicado: (2021)

Pharmacokinetics and tissue residue of enrofloxacin in healthy, Eimeria-infected broiler chickens and those pre-treated with amprolium and toltrazuril
por: Atef, M., et al.
Publicado: (2020)

The effect of enrofloxacin on enteric Escherichia coli: Fitting a mathematical model to in vivo data
por: Erwin, Samantha, et al.
Publicado: (2020)

Synthesis, Characterization, and Pharmacodynamics Study of Enrofloxacin Mesylate
por: Pei, Lin-lin, et al.
Publicado: (2020)

Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks
por: Yu, Yang, et al.
Publicado: (2017)

Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs
por: Lei, Zhixin, et al.
Publicado: (2017)

Pharmacokinetics of enrofloxacin HCl-2H(2)O (Enro-C) in dogs and pharmacokinetic/pharmacodynamic Monte Carlo simulations against Leptospira spp.
por: Sumano, Hector, et al.
Publicado: (2018)

Dose-dependent impact of enrofloxacin on broiler chicken gut resistome is mitigated by synbiotic application
por: Temmerman, Robin, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Integration of Enrofloxacin Following Single Oral Administration of Different Doses in Brown Trout (Salmo trutta)
por: Uney, Kamil, et al.
Publicado: (2021)

The effects of cyclosporine A or activated charcoal co-administration on the pharmacokinetics of enrofloxacin in chickens
por: Petkova, Tsvetelina, et al.
Publicado: (2022)

Effect of administration route and dose escalation on plasma and intestinal concentrations of enrofloxacin and ciprofloxacin in broiler chickens
por: Devreese, Mathias, et al.
Publicado: (2014)

Evaluation of the Presence and Levels of Enrofloxacin, Ciprofloxacin, Sulfaquinoxaline and Oxytetracycline in Broiler Chickens after Drug Administration
por: de Assis, Débora Cristina Sampaio, et al.
Publicado: (2016)

Age-Related P-Glycoprotein Expression in the Intestine and Affecting the Pharmacokinetics of Orally Administered Enrofloxacin in Broilers
por: Guo, Mengjie, et al.
Publicado: (2013)

Pharmacokinetics and Pharmacodynamics of Butorphanol and Dexmedetomidine after Intranasal Administration in Broiler Chickens (Gallus gallus domesticus)
por: Sha, Jin, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Modeling of Spiramycin against Mycoplasma synoviae in Chickens
por: Elazab, Sara T., et al.
Publicado: (2021)

Longitudinal Surveillance and Risk Assessment of Resistance in Escherichia coli to Enrofloxacin from A Large-Scale Chicken Farm in Hebei, China
por: Guo, Kaixuan, et al.
Publicado: (2021)

E. coli Infection Modulates the Pharmacokinetics of Oral Enrofloxacin by Targeting P-Glycoprotein in Small Intestine and CYP450 3A in Liver and Kidney of Broilers
por: Guo, Mengjie, et al.
Publicado: (2014)

Antimicrobial resistance of Escherichia coli isolates from broiler chickens and humans
por: Miles, Tricia D, et al.
Publicado: (2006)

Broiler Chickens as Source of Human Fluoroquinolone-Resistant Escherichia coli, Iceland
por: Thorsteinsdottir, Thorunn R., et al.
Publicado: (2010)

Efficacy of Cefquinome against Escherichia coli Environmental Mastitis Assessed by Pharmacokinetic and Pharmacodynamic Integration in Lactating Mouse Model
por: Yu, Yang, et al.
Publicado: (2017)

Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model Systems
por: VanScoy, Brian D., et al.
Publicado: (2021)

Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
por: Seeger, Johanna, et al.
Publicado: (2021)

Resistance of Escherichia coli in Turkeys after Therapeutic or Environmental Exposition with Enrofloxacin Depending on Flooring
por: Chuppava, Bussarakam, et al.
Publicado: (2018)

Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken
por: Bhutto, Zohaib Ahmed, et al.
Publicado: (2018)

Integrated pharmacokinetics/pharmacodynamics parameters-based dosing guidelines of enrofloxacin in grass carp Ctenopharyngodon idella to minimize selection of drug resistance
por: Xu, Lijuan, et al.
Publicado: (2013)

1560. Pharmacokinetics–Pharmacodynamics (PK-PD) of Gepotidacin (GEP) Against Escherichia coli in Murine Pyelonephritis and Thigh Infection Models
por: Barth, Aline, et al.
Publicado: (2019)

Spleen transcriptome response to infection with avian pathogenic Escherichia coli in broiler chickens
por: Sandford, Erin E, et al.
Publicado: (2011)

Virulence Genes Content and Antimicrobial Resistance in Escherichia coli from Broiler Chickens
por: Mohamed, Moemen A., et al.
Publicado: (2014)

Molecular characterization of avian pathogenic Escherichia coli from broiler chickens with colibacillosis
por: Kim, Yeong Bin, et al.
Publicado: (2019)

Effects of the prebiotic lactoferrin on multidrug-resistant Escherichia coli infections in broiler chickens
por: Badr, Heba, et al.
Publicado: (2021)

Interleukin gene expression in broiler chickens infected by different Escherichia coli serotypes
por: Elnagar, Reham, et al.
Publicado: (2021)

The Use of Lavender (Lavandula angustifolia) Essential Oil as an Additive to Drinking Water for Broiler Chickens and Its In Vitro Reaction with Enrofloxacin
por: Adaszyńska-Skwirzyńska, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rub7kjkqb6tue0otdr0ep34dib